Current Ratio: A liquidity ratio that measures a company's ability to pay short-term obligations. Calculated as: Total Current Assets / Total Current Liabilities
Theriva Biologics, Inc. (TOVX) had Current Ratio of 0.90 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-4.36M |
|
-- |
|
-- |
|
$4.44M |
|
$-4.44M |
|
$0.08M |
|
$-4.36M |
|
$-4.36M |
|
$-4.36M |
|
$-4.36M |
|
$-4.36M |
|
$-4.36M |
|
$-4.44M |
|
$-4.41M |
|
9.68M |
|
9.68M |
|
$-0.45 |
|
$-0.45 |
|
| Balance Sheet Financials | |
$9.90M |
|
$0.25M |
|
$20.93M |
|
$30.84M |
|
$11.00M |
|
$1.65M |
|
$13.10M |
|
$24.10M |
|
$6.74M |
|
$6.74M |
|
$6.74M |
|
10.30M |
|
| Cash Flow Statement Financials | |
$-13.79M |
|
$-0.04M |
|
$9.73M |
|
$11.71M |
|
$7.57M |
|
$-4.13M |
|
$0.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
|
Current Ratio |
0.90 |
-- |
|
-- |
|
0.20 |
|
0.25 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.82M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-64.72% |
|
-64.72% |
|
-14.14% |
|
-51.97% |
|
$0.65 |
|
$-1.43 |
|
$-1.42 |
|